Sharon Nations, M.D. Professor School Medical School Department Neurology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Joined UT Southwestern: 1996 Sharon Pond Nations, M.D., is a Professor in the Department of Neurology at UT Southwestern Medical Center. She specializes in neuromuscular disorders. Research: Dr. Nations’ research interests include ALS, myasthenia gravis, myopathies and CIDP, and she has been involved in multiple clinical trials in these areas. She serves as a reviewer for Archives of Neurology, Neurology, Clinical Neuromuscular Disorders, and Muscle & Nerve. Background: Dr. Nations earned her medical degree at the University of Texas Medical Branch at Galveston. She completed a residency in neurology at Baylor College of Medicine. She received advanced training through a fellowship in neurophysiology at UT Southwestern. Certified by the American Board of Psychiatry and Neurology, Dr. Nations joined the UT Southwestern faculty in 1996. Education Medical School University of Texas Medical Branch at Galveston (1981) Internship North Carolina Baptist Hospital (1982), Neurology Residency Baylor College of Medicine (1985), Neurology Fellowship Parkland Health and Hospital System (1996), Neurophysiology Research Interest ALS Myasthenia gravis Myopathies Publications Featured Publications Primary lateral sclerosis: consensus diagnostic criteria. Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, Ravits J, Silani V, Simmons Z, Statland J, van den Berg LH, Mitsumoto H, J. Neurol. Neurosurg. Psychiatry 2020 Apr 91 4 373-377 Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Mitsumoto H, Garofalo DC, Santella RM, Sorenson EJ, Oskarsson B, Fernandes JAM, Andrews H, Hupf J, Gilmore M, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Nations SP, Swenson AJ, Factor-Litvak P, Amyotroph Lateral Scler Frontotemporal Degener 2020 Apr 1-10 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab. Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF, J. Neurol. 2020 Mar Primary lateral sclerosis (PLS) functional rating scale: PLS-specific clinimetric scale. Mitsumoto H, Chiuzan C, Gilmore M, Zhang Y, Simmons Z, Paganoni S, Kisanuki YY, Zinman L, Jawdat O, Sorenson E, Floeter MK, Pioro EP, Fernandes Filho JAM, Heitzman D, Fournier CN, Oskarsson B, Heiman-Patterson T, Maragakis N, Joyce N, Hayat G, Nations S, Scelsa S, Walk D, Elman L, Hupf J, McHale B, Muscle Nerve 2020 02 61 2 163-172 Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA, Lancet Neurol 2019 Sep 18 9 834-844 Eculizumab improves fatigue in refractory generalized myasthenia gravis. Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF, Qual Life Res 2019 Mar Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR, Lancet Neurol 2019 03 18 3 259-268 Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status. Usmani A, Kwan L, Wahib-Khalil D, Trivedi J, Nations S, Sarode R J Clin Apher 2019 Feb Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, De Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Muscle Nerve 2019 Feb Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial. Statland JM, Moore D, Wang Y, Walsh M, Mozaffar T, Elman L, Nations SP, Mitsumoto H, Fernandes JA, Saperstein D, Hayat G, Herbelin L, Karam C, Katz J, Wilkins HM, Agbas A, Swerdlow RH, Santella RM, Dimachkie MM, Barohn RJ Muscle Nerve 2019 Feb 59 2 201-207 Results 1-10 of 25 1 2 3 Next Last Books Featured Books Infectious and Granulomatous Neuropathies. In Handbook of Peripheral Neuropathy Bromberg and Smith (). New York, Marcel Dekker Motor Neuron Diseases. In Physical Medicine & Rehabilitation Braddom Et al. (2007). Saunders Elsevier A 34 year old man with right hand and left foot numbness. In A Case-based Guide to Neuromuscular Pathology Zhou, Burns, Cai (2020). Switzerland, Springer Nature Professional Associations/Affiliations American Academy of Neurology (1996) American Association of Neuromuscular and Electrodiagnostic Medicine (1999)
